Decision-making in the cancer pain setting: Beyond the WHO ladder

Aragon-Poce, 2002, History of opium, Int Congr Ser, 1242, 19, 10.1016/S0531-5131(02)00600-3 Goodrich, 2004, History of spine surgery in the ancient and medieval worlds, Neurosurg Focus, 16, E2, 10.3171/foc.2004.16.1.3 Bonica, 1979, Importance of the problem, 1 Meldrum, 2005, The ladder and the clock: Cancer pain and public policy at the end of the twentieth century, J Pain Symptom Manage, 29, 41, 10.1016/j.jpainsymman.2004.08.004 Stjernswärd, 1995, Opioid availability and cancer pain: An unnecessary tragedy, Support Care Cancer, 3, 157, 10.1007/BF00368882 Ahmedzai, 1997, New approaches to pain control in patients with cancer, Eur J Cancer, 33, S8, 10.1016/S0959-8049(97)00205-0 Benyamin, 2008, Opioid complications and side effects, Pain Physician, 11, S105, 10.36076/ppj.2008/11/S105 Pacifici, 1994, Effect of morphine and methadone acute treatment on immunological activity in mice: Pharmacokinetic and pharmacodynamic correlates, J Pharmacol Exp Ther, 269, 1112 Villars, 2007, Difference in the prevalence and severity of side effects based on type of analgesic prescription in patients with chronic cancer pain, J Pain Symptom Manage, 33, 67, 10.1016/j.jpainsymman.2006.07.011 Gupta, 2002, Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth, Cancer Res, 62, 4491 Poonawala, 2005, Opioids heal ischemic wounds in the rat, Wound Repair Regen, 13, 165, 10.1111/j.1067-1927.2005.130207.x Zagon, 1983, Naltrexone modulates tumor response in mice with neuroblastoma, Science, 221, 671, 10.1126/science.6867737 Farooqui, 2007, COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumor growth, metastasis and mortality, without compromising analgesia, Br J Cancer, 97, 1523, 10.1038/sj.bjc.6604057 Aloisi, 2005, Gender-related effects of chronic non-malignant pain and opioid therapy on plasma levels of macrophage inhibitory factor (MIF), Int J Dev Neurosci, 23, 621 Daniell, 2006, Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency, J Pain, 7, 200, 10.1016/j.jpain.2005.10.009 Daniell, 2008, Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain, J Pain, 9, 28, 10.1016/j.jpain.2007.08.005 Kaergaard, 2000, Association between plasma testosterone and work-related neck and shoulder disorders among female workers, Scand J Work Environ Health, 26, 292, 10.5271/sjweh.545 English, 2000, Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study, Circulation, 102, 1906, 10.1161/01.CIR.102.16.1906 Pirnik, 2001, Single dose of morphine influences plasma corticosterone and gene expression of main NMDA receptor subunit in the adrenal gland but not in the hippocampus, Endocr Regul, 35, 187 Chu, 2008, Opioid induced hyperalgesia in humans: Molecular mechanisms and clinical considerations, Clin J Pain, 24, 479, 10.1097/AJP.0b013e31816b2f43 King, 2005, Is paradoxical pain induced by sustained opioid exposure an underlying mechanism of opioid antinociceptive tolerance?, Neuro Signals, 14, 194, 10.1159/000087658 Huang, 1996, Vertebral fracture and other predictors of physical impairment and health care utilization, Arch Intern Med, 156, 2469, 10.1001/archinte.1996.00440200087011 Lindsay, 2001, Risk of new vertebral fracture in the year following a fracture, JAMA, 285, 320, 10.1001/jama.285.3.320 Charnley, 1970, The reaction of bone to self-curing acrylic cement: A long-term histological study in man, J Bone Joint Surg Br, 52, 340, 10.1302/0301-620X.52B2.340 Liberman, 2001, Initial outcome and efficacy of “kyphoplasty” in the treatment of painful osteoporotic vertebral compression fractures, Spine, 26, 1631, 10.1097/00007632-200107150-00026 Burton, 2008, Kyphoplasty and vertebroplasty, Curr Pain Headache Rep, 12, 22, 10.1007/s11916-008-0005-6 McKiernan, 2004, Quality of life following vertebroplasty, J Bone Joint Surg Am, 86-A, 2600, 10.2106/00004623-200412000-00003 McGraw, 2003, Society of International Radiology quality improvement guidelines for percutaneous vertebroplasty, J Vasc Interv Radiol, 14, 827, 10.1016/S1051-0443(07)60242-5 Phillips, 2002, An in vivo comparison of the potential for extravertebral cement leak after vertebroplasty and kyphoplasty, Spine, 27, 2173, 10.1097/00007632-200210010-00018 Walker, 2004, Infected vertebroplasty, Neurosurg Focus, 17, E6, 10.3171/foc.2004.17.6.6 O'Brien, 2000, Vertebroplasty in patients with severe vertebral compression fractures: A technical report, AJNR Am J Neuroradiol, 21, 1555 Peh, 2002, Percutaneous vertebroplasty for severe osteoporotic vertebral body compression fractures, Radiology, 223, 121, 10.1148/radiol.2231010234 Burton, 2005, Percutaneous vertebroplasty—A technique to treat refractory spinal pain in the setting of advanced metastatic cancer: A case series, J Pain Symptom Manage, 30, 87, 10.1016/j.jpainsymman.2004.12.011 Jensen, 1997, Percutaneous polymethylmethacrylate vertebroplasty in the treatment of osteoporotic vertebral body compression fractures: Technical aspects, AJNR Am J Neuroradiol, 18, 1897 2004 Ghaneh, 2007, Biology and management of pancreatic cancer, Gut, 56, 1134 Li, 2004, Pancreatic cancer, Lancet, 363, 1049, 10.1016/S0140-6736(04)15841-8 Brescia, 1992, Pain, opioid use, and survival in hospitalized patients with advanced cancer, J Clin Oncol, 10, 149, 10.1200/JCO.1992.10.1.149 Cruciani, 2008, Pancreatic pain: A mini review, Pancreatology, 8, 230, 10.1159/000134278 Ward, 1979, The celiac ganglia in man: Normal anatomic variations, Anesth Analg, 58, 461, 10.1213/00000539-197911000-00004 Eisenberg, 1995, Neurolytic celiac plexus block for treatment of cancer pain: A meta-analysis, Anesth Analg, 80, 290 Wong, 2004, Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: A randomized controlled trial, JAMA, 291, 1092, 10.1001/jama.291.9.1092 Yan, 2007, Neurolytic celiac plexus block for pain control in unresectable pancreatic cancer, Am J Gastroenterol, 102, 430, 10.1111/j.1572-0241.2006.00967.x